Last reviewed · How we verify

NCT05869526

A Comparison of the Effects of Krill Oil and Fish Oil Supplementation on Muscle Function in Older Adults

Completed NA Last updated 30 March 2025
What this trial tests

NA trial testing Fish oil in Sarcopenia in 61 participants. Completed in 1 April 2024.

Timeline
1 May 2023
Primary endpoint
1 February 2024
1 April 2024

Quick facts

Lead sponsorUniversity of Glasgow
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposeprevention
Enrollment61
Start date1 May 2023
Primary completion1 February 2024
Estimated completion1 April 2024
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Glasgow

Who can join

Adults 60 to 90, any sex, with Sarcopenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to compare the effects of Krill Oil and Fish Oil supplementation on muscle function in older adults. The secondary aim is to investigate the mechanisms underlying the beneficial effects previously observed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Fish oil

Trials testing the same drug.

Other recruiting trials for Sarcopenia

Currently open trials in the same condition.

Other University of Glasgow trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05869526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing